Context: Although tissue plasminogen activator (tPA) is an effective treatment for stroke patients, it typically must be administered within 3 hours of symptom onset to substantially reduce morbidity and mortality. Because of this limited treatment window, it is essential for healthcare professionals to properly identify and quickly triage stroke patients.

Objective: To determine if implementation of a stroke alert protocol coupled with a limited education program will reduce arrival time to computed tomography scan time and treatment time for stroke patients in the emergency department (ED).

Methods: This prospective pilot study took place at Geisinger Medical Center in Danville, Pennsylvania, and included a formal stroke protocol based partly on The Joint Commission's stroke center recommendations. The major feature was integration of various hospital departments to quickly and accurately identify and triage stroke patients; included was a limited education program for residents and attending staff. Patients who presented between November 1, 2007, to October 31, 2008, comprised the study group (ie, after protocol implementation). A retrospective analysis of patient records from November 1, 2006, to October 31, 2007, for stroke morbidity, mortality, and tPA administration was employed as a control group (ie, prior to protocol implementation). Inclusion criteria consisted of patients aged 18 years or older who arrived at the ED with stroke-like symptoms. Exclusion criteria consisted of previous hemorrhagic stroke, seizure at stroke onset, internal bleeding, intracranial hemorrhage, recent surgery, platelet count of less than 100 × 10(3)/μL, untreated blood pressure greater than 185/110 mm Hg, symptoms lasting for longer than 6 hours, and vascular malformation. Patients with a history of ischemic stroke were included in the study.

Results: The study included a total of 233 stroke patients, 132 of whom presented to the ED prior to stroke protocol implementation and 101 of whom presented after stroke protocol implementation. For patients who arrived at the ED within 3 hours from symptom onset, median time to completion of a computed tomography (CT) scan was reduced from 65.5 minutes (interquartile range, 41.0-101.0) prior to the new protocol to 54.0 minutes (interquartile range, 25.0-54.0) after implementation (P<.004). Regarding patients who arrived in the ED 3 to 6 hours after symptom onset, median time from ED arrival to CT time decreased from 94.5 minutes (interquartile range, 68.0-136.0) before the new protocol to 48.5 minutes (interquartile range, 33.0-89.0) following implementation (P<.002). Of the 79 patients who arrived at the ED within 3 hours of symptom onset in the year after protocol implementation, 12 were treated with tPA, compared to 4 out of 86 treated in the year prior to protocol implementation. Mean time from ED arrival to tPA treatment was reduced from 85.5 minutes in the preprotocol group to 48.9 minutes in the postprotocol group.

Conclusion: By coupling a formal stroke protocol with a limited education program, door-to-treatment time of stroke patients was reduced.

Download full-text PDF

Source

Publication Analysis

Top Keywords

stroke patients
16
protocol implementation
16
stroke
14
stroke protocol
12
implementation stroke
8
stroke alert
8
protocol
8
alert protocol
8
emergency department
8
pilot study
8

Similar Publications

Outcomes for Children With Congenital Heart Disease Undergoing Ventricular Assist Device Implantation: An ACTION Registry Analysis.

J Am Coll Cardiol

December 2024

Division of Cardiology, Department of Pediatrics, University of Pennsylvania Perelman School of Medicine, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.

Background: There are no contemporary reports that highlight the national outcomes for children with congenital heart disease (CHD) undergoing ventricular assist device (VAD) implantation.

Objectives: This study sought to evaluate differences in VAD outcomes for children with CHD to those with non-CHD as well as those with univentricular CHD to those with biventricular CHD.

Methods: Data for CHD and non-CHD patients from the multicenter ACTION (Advanced Cardiac Therapies Improving Outcomes Network) undergoing VAD implantation from April 2018 to February 2023 were included.

View Article and Find Full Text PDF

Preoperative Telerehabilitation Improves Outcomes After Cardiac Surgery.

J Am Coll Cardiol

December 2024

Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York, USA.

View Article and Find Full Text PDF

Cost-Effectiveness of Semaglutide in Patients With Obesity and Cardiovascular Disease.

Can J Cardiol

December 2024

Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada; Department of Medicine, University of Calgary, Calgary, Alberta, Canada; O'Brien Institute for Public Health, University of Calgary, Calgary, Alberta, Canada; Department of Cardiac Sciences, University of Calgary, Calgary, Alberta, Canada. Electronic address:

Background: Randomized clinical trials have shown that semaglutide is associated with a clinically relevant reduction in body weight and a lower risk of adverse cardiovascular events in those who are overweight or obese with a history of cardiovascular disease but no diabetes. The objective of this study was to assess the cost-effectiveness of semaglutide for this indication.

Methods: A decision analytic Markov model was used to compare the lifetime benefits and costs of semaglutide 2.

View Article and Find Full Text PDF

A NIRS-Based Technique for Monitoring Brain Tissue Oxygenation in Stroke Patients.

Sensors (Basel)

December 2024

Division of Neurological Rehabilitiation, Instituto Nacional de Rehabilitacion Luis Guillermo Ibarra Ibarra, Mexico City 14389, Mexico.

Stroke is a global health issue caused by reduced blood flow to the brain, which leads to severe motor disabilities. Measuring oxygen levels in the brain tissue is crucial for understanding the severity and evolution of stroke. While CT or fMRI scans are preferred for confirming a stroke due to their high sensitivity, Near-Infrared Spectroscopy (NIRS)-based systems could be an alternative for monitoring stroke evolution.

View Article and Find Full Text PDF

Molecular Targeting of Ischemic Stroke: The Promise of Naïve and Engineered Extracellular Vesicles.

Pharmaceutics

November 2024

Laboratory of Stem Cells and Tissue Regeneration, Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea.

Ischemic stroke (IS) remains a leading cause of mortality and long-term disability worldwide, with limited therapeutic options available. Despite the success of early interventions, such as tissue-type plasminogen activator administration and mechanical thrombectomy, many patients continue to experience persistent neurological deficits. The pathophysiology of IS is multifaceted, encompassing excitotoxicity, oxidative and nitrosative stress, inflammation, and blood-brain barrier disruption, all of which contribute to neural cell death, further complicating the treatment of IS.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!